LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

JNJ

153.08

-0.26%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

JNJ

153.08

-0.26%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

JNJ

153.08

-0.26%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

JNJ

153.08

-0.26%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

JNJ

153.08

-0.26%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

Search

Bio-Techne Corp

Cerrado

Sector Salud

72.73 -2.97

Resumen

Variación precio

24h

Actual

Mínimo

72.41

Máximo

72.88

Métricas clave

By Trading Economics

Ingresos

-7M

34M

Ventas

-17M

290M

P/B

Media del Sector

76.615

59.362

BPA

0.42

Rentabilidad por dividendo

0.4

Margen de beneficio

11.606

EBITDA

8.9M

81M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+20.27 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.40%

2.35%

Próximas Ganancias

30 abr 2025

Fecha Próximo Dividendo

28 feb 2025

Próxima Fecha de Ex Dividendo

14 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

12B

Apertura anterior

75.7

Cierre anterior

72.73

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Bio-Techne Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 feb 2025, 22:54 UTC

Adquisiciones, fusiones, absorciones

Digital Asset Acquisition and Real Asset Acquisition File for IPOs

8 feb 2025, 11:00 UTC

Principales Noticias
Ganancias

Coach, Ralph Lauren Hit the Right Price for Affordable Luxury -- Heard on the Street -- WSJ

8 feb 2025, 09:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 feb 2025, 00:50 UTC

Adquisiciones, fusiones, absorciones

Trump Opens Door for New Nippon Steel Deal to Move Forward -- 3rd Update

7 feb 2025, 22:47 UTC

Ganancias

Spotify Stock Set to Rise on Continuing Growth. Plus, Deere, Palantir, and More. -- Barrons.com

7 feb 2025, 22:24 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Trump Opens Door for New Nippon Steel Deal to Move Forward -- 2nd Update

7 feb 2025, 22:20 UTC

Principales Noticias

Trump Administration Halts Funding for Build-out of Highway EV Chargers -- Update

7 feb 2025, 22:18 UTC

Ganancias

Value Stocks Are Outearning Forecasts. Why JPMorgan, IBM, and Ford Look Like Winners. -- Barrons.com

7 feb 2025, 21:58 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Alphabet Sells All of Its Snowflake Stock -- Barrons.com

7 feb 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

7 feb 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

7 feb 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

7 feb 2025, 21:26 UTC

Principales Noticias

Nasdaq, Dow Fall Amid Tariff Fears and Mixed Jobs Report -- WSJ

7 feb 2025, 21:24 UTC

Ganancias

Friedman Industries: Expects 4Q Sales Volume to Be Higher Than 3Q >FRD

7 feb 2025, 21:24 UTC

Ganancias

Friedman Industries 3Q Sales $94.1M >FRD

7 feb 2025, 21:23 UTC

Ganancias

Friedman Industries 3Q Loss/Shr 17c >FRD

7 feb 2025, 21:22 UTC

Principales Noticias

Employers Added 143,000 Jobs in January, and Unemployment Edged Down to 4% -- 4th Update

7 feb 2025, 21:19 UTC

Adquisiciones, fusiones, absorciones

U.S. Steel Stock Drops. Trump Is Altering the Deal With Nippon. -- Barrons.com

7 feb 2025, 21:18 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Trump Opens Door for New Nippon Steel Deal to Move Forward -- Update

7 feb 2025, 21:09 UTC

Charlas de Mercado

Sea-Change on Housing Required to Tackle Canada's Productivity Malaise -- Market Talk

7 feb 2025, 20:42 UTC

Charlas de Mercado

U.S. Natural Gas Posts Weekly Gain as Winter Remains -- Market Talk

7 feb 2025, 20:40 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Palantir Stock's Great Week, and a MicroStrategy Security to Buy Now -- Barrons.com

7 feb 2025, 20:38 UTC

Charlas de Mercado

Oil Futures Post Third Straight Weekly Loss -- Market Talk

7 feb 2025, 20:28 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Trump Opens Door for New Nippon Steel Deal to Move Forward -- WSJ

7 feb 2025, 20:26 UTC

Principales Noticias

Senate Republicans Move to Deliver Quick Border Win for Trump -- WSJ

7 feb 2025, 20:23 UTC

Adquisiciones, fusiones, absorciones

U.S. Steel Stock Is Dropping. Trump Is Altering the Deal With Nippon. -- Barrons.com

7 feb 2025, 20:15 UTC

Ganancias

These Stocks Are Moving the Most Today: Amazon, Tesla, Uber, Affirm, Pinterest, Take-Two, Expedia, Bill, e.l.f. Beauty, and More -- Barrons.com

7 feb 2025, 20:10 UTC

Charlas de Mercado

Gold Rises for Sixth Straight Week -- Market Talk

7 feb 2025, 19:48 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

U.S. Steel Stock Is Dropping. Trump Is Altering the Deal With Nippon. -- Barrons.com

7 feb 2025, 19:12 UTC

Ganancias

Expedia Stock Surges on Strong Earnings. What Analysts Are Saying. -- Barrons.com

Comparación entre iguales

Cambio de precio

Bio-Techne Corp Esperado

Precio Objetivo

By TipRanks

20.27% repunte

Estimación a 12 meses

Media 87.57 USD  20.27%

Máximo 95 USD

Mínimo 75 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bio-Techne Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

5

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

72.41 / 73.56Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

157 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.